Rihab Yassin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rihab Yassin has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Nicole Lockhart
Office of Biorepositories and Biospecimen Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
2 shared publications- Carol J. Weil
Division of Cancer Treatment and Diagnosis, Diagnostics Evaluation Branch, Cancer Diagnosis Program, National Cancer Institute, National Institutes of Health, Bethesda, USA
1 shared publication Carolyn Compton
Office of Biorepositories and Biospecimen Research, National Cancer Institute, Bethesda, MD
1 shared publicationJeffrey W. Thomas
Technology Transfer Center, National Cancer Institute, Bethesda, MD
1 shared publicationKaren Pitt
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD
1 shared publicationLinda Weiss
Office of Cancer Centers, National Cancer Institute, Bethesda, MD
1 shared publication
Latest Publications
- Open Access
- 1 February 2012
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 21 (2) , 256-259
Sharing Individual Research Results with Biospecimen Contributors: Point
Biospecimens are an essential resource for biomedical research, including research that aims to decipher the biology of cancer and improve its clinical management. Accordingly, patients with cancer and others who contribute biospecimens for research are increasingly attentive to the results of
- 1 February 2012
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 21 (2) , 256-259
Open AccessSharing Individual Research Results with Biospecimen Contributors: Point
Biospecimens are an essential resource for biomedical research, including research that aims to decipher the biology of cancer and improve its clinical management. Accordingly, patients with cancer and others who contribute biospecimens for research are increasingly attentive to the results of
- Open Access
- 1 April 2010
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 19 (4) , 1012-1015
Custodianship as an Ethical Framework for Biospecimen-Based Research
Human biological specimens (biospecimens) are increasingly important for research that aims to advance human health. Yet, despite significant proliferation in specimen-based research and discoveries during the past decade, research remains challenged by the inequitable access to high-quality biospecimens that are collected under rigorous ethical standards. This is primarily caused by the complex level of control and ownership exerted by the myriad of stakeholders involved in the biospecimen research process. This article discusses the ethical model of custodianship as a framework for biospecimen-based research to promote fair research access and resolve issues of control and potential conflicts between biobanks, investigators, human research participants (human subjects), and sponsors. Custodianship is the caretaking obligation for biospecimens from initial collection to final dissemination of research findings. It endorses key practices and operating principles for responsible oversight of biospecimens collected for research. Embracing the custodial model would ensure transparency in research, fairness to human research participants, and shared accountability among all stakeholders involved in biospecimen-based research. Cancer Epidemiol Biomarkers Prev; 19(4); 1012–5. ©2010 AACR.
- 1 April 2010
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 19 (4) , 1012-1015
Open AccessCustodianship as an Ethical Framework for Biospecimen-Based Research
Human biological specimens (biospecimens) are increasingly important for research that aims to advance human health. Yet, despite significant proliferation in specimen-based research and discoveries during the past decade, research remains challenged by the inequitable access to high-quality biospecimens that are collected under rigorous ethical standards. This is primarily caused by the complex level of control and ownership exerted by the myriad of stakeholders involved in the biospecimen research process. This article discusses the ethical model of custodianship as a framework for biospecimen-based research to promote fair research access and resolve issues of control and potential conflicts between biobanks, investigators, human research participants (human subjects), and sponsors. Custodianship is the caretaking obligation for biospecimens from initial collection to final dissemination of research findings. It endorses key practices and operating principles for responsible oversight of biospecimens collected for research. Embracing the custodial model would ensure transparency in research, fairness to human research participants, and shared accountability among all stakeholders involved in biospecimen-based research. Cancer Epidemiol Biomarkers Prev; 19(4); 1012–5. ©2010 AACR.